upfront treatment in transplant candidates
Published 4 years ago • 41 plays • Length 5:18Download video MP4
Download video MP3
Similar videos
-
2:18
evolving treatment options in ndmm: transplant-eligible and transplant-ineligible patients
-
3:03
post-transplant complications and their management
-
3:40
master class in transplantation and hematology: highlights
-
2:13
frontline treatment of transplant eligible patients with myeloma: current approach & future changes
-
1:30
exploring the role of upfront autosct in multiple myeloma
-
21:38
drawing the line: the rationale behind blood tube collection order
-
5:31
how will ai tools and llms help to transform medicine and cancer care in the future?
-
3:32
the challenges with implementing ai in cancer care: building trust in ai technologies
-
3:50
advances in the prevention and treatment of gvhd
-
1:05
optimizing the treatment of transplant-eligible ndmm: using quadruplets in induction & consolidation
-
1:39
transplant vod: key issues
-
2:30
systematic review comparing allogeneic transplant patients with non-transplant patients in mf
-
1:56
the feasibility of chemotherapy-free regimens without allogeneic transplantation in mrd- ph all
-
1:03
the importance of the mdt in managing transplant survivors
-
4:25
the role of the pharmacist in interpreting & applying pgx results in transplant recipients
-
1:26
improving survivorship care in transplant recipients
-
1:32
gvhd highlights: use of biomarkers to guide treatment
-
2:00
the effectiveness of ambulatory care for patients undergoing stem cell transplantation
-
4:44
advances in the treatment of transplant-eligible and ineligible multiple myeloma
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
4:09
veno-occlusive disease as a post-transplant complication of hsct
-
0:49
advances in gvhd and maintenance following transplant